Skip to main content

Advertisement

Log in

„Asymptomatisches WPW“

Bedarf es einer Therapie?

“Asymptomatic WPW”

Is treatment necessary?

  • Schwerpunkt
  • Published:
Herzschrittmachertherapie + Elektrophysiologie Aims and scope Submit manuscript

Zusammenfassung

Der Begriff „asymptomatisches WPW“ wird als Synonym für eine ventrikuläre Präexzitation vom WPW (Wolff-Parkinson-White) Typ aufgrund einer akzessorischen Leitungsbahn verwendet, die sich im Elektrokardiogramm (EKG) im Sinusrhythmus durch eine kurze PQ-Zeit mit Deltawelle manifestiert, ohne dass es bei den Betroffenen zum Auftreten von paroxysmalen Tachykardien kommt. Häufig wird das asymptomatische WPW als Zufallsbefund bei jüngeren Personen ohne sonstige kardiale Auffälligkeiten diagnostiziert. Es besteht ein geringes Risiko des plötzlichen Herztods durch eine schnelle Überleitung auf die Herzkammern über die akzessorische Bahn bei Vorhofflimmern. In diesem Artikel werden verschiedene Aspekte zur nichtinvasiven und invasiven Risikostratifizierung, zur Therapie durch Katheterablation und zur individuellen Risk-Benefit-Diskussion bei asymptomatischem WPW beleuchtet.

Abstract

The term “asymptomatic WPW” (Wolff–Parkinson–White) is often used as a synonym for ventricular pre-excitation of the WPW type due to an accessory pathway characterized by a short PR interval and a delta wave on the electrocardiogram (ECG) without the clinical occurrence of paroxysmal tachycardia. Asymptomatic WPW is often diagnosed in young and otherwise healthy people. There is a small associated risk of sudden cardiac death due to rapid antegrade conduction over the accessory pathway during atrial fibrillation. This paper highlights aspects of noninvasive and invasive risk stratification, therapy by catheter ablation, and the ongoing risk–benefit discussion in asymptomatic WPW.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Wolff L, Parkinson J, White PD (2006) Bundle-branch block with short P‑R interval in healthy young people prone to paroxysmal tachycardia. 1930. Ann Noninvasive Electrocardiol 11(4):340–353

    Article  PubMed  PubMed Central  Google Scholar 

  2. Holzmann M (1932) Über Elektrokardiogramme mit verkürzter Vorhofkammer – Distanz und positive P‑Zacken. Z Klin Med 121:404

    Google Scholar 

  3. Cohen MI et al (2012) PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the pediatric and congenital electrophysiology society (PACES) and the heart rhythm society (HRS). Endorsed by the governing bodies of PACES, HRS, the American college of cardiology foundation (ACCF), the American heart association (AHA), the American academy of pediatrics (AAP), and the Canadian heart rhythm society (CHRS). Heart Rhythm 9(6):1006–1024

    Article  PubMed  Google Scholar 

  4. Emmel M, Balaji S, Sreeram N (2004) Ventricular preexcitation associated with dilated cardiomyopathy: a causal relationship? Cardiol Young 14(6):594–599

    Article  PubMed  Google Scholar 

  5. Montoya PT et al (1991) Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Eur Heart J 12(2):144–150

    Article  CAS  PubMed  Google Scholar 

  6. Timmermans C et al (1995) Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol 76(7):492–494

    Article  CAS  PubMed  Google Scholar 

  7. Munger TM et al (1993) A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953–1989. Circulation 87(3):866–873

    Article  CAS  PubMed  Google Scholar 

  8. Santinelli V et al (2009) The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children. J Am Coll Cardiol 53(3):275–280

    Article  PubMed  Google Scholar 

  9. Dreifus LS et al (1971) Ventricular fibrillation. A possible mechanism of sudden death in patients and Wolff-Parkinson-White syndrome. Circulation 43(4):520–527

    Article  CAS  PubMed  Google Scholar 

  10. Fukatani M et al (1990) Prediction of a fatal atrial fibrillation in patients with asymptomatic Wolff-Parkinson-White pattern. Jpn Circ J 54(10):1331–1339

    Article  CAS  PubMed  Google Scholar 

  11. Pietersen AH, Andersen ED, Sandøe E (1992) Atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Cardiol 70(5):38a–43a

    Article  CAS  PubMed  Google Scholar 

  12. Rao AL et al (2014) Evaluation and management of Wolff-Parkinson-White in athletes. Sports Health 6(4):326–332

    Article  PubMed  PubMed Central  Google Scholar 

  13. Arnar DO et al (2019) Management of asymptomatic arrhythmias: a European heart rhythm association (EHRA) consensus document, endorsed by the heart failure association (HFA), heart rhythm society (HRS), asia pacific heart rhythm society (APHRS), cardiac arrhythmia society of southern africa (CASSA), and latin america heart rhythm society (LAHRS). Europace 21(6):844–845

    Article  PubMed  Google Scholar 

  14. Pappone C et al (2003) Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol 41(2):239–244

    Article  PubMed  Google Scholar 

  15. Etheridge SP et al (2018) Life-threatening event risk in children with Wolff-Parkinson-White syndrome: a multicenter international study. JACC Clin Electrophysiol 4(4):433–444

    Article  PubMed  Google Scholar 

  16. Page RL et al (2016) 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol 67(13):e27–e115

    Article  PubMed  Google Scholar 

  17. Zipes DP et al (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American heart association and American college of cardiology. J Am Coll Cardiol 66(21):2412–2423

    Article  PubMed  Google Scholar 

  18. Brembilla-Perrot B, Girerd N, Sellal JM (2018) Unresolved questions associated with the management of ventricular preexcitation syndrome. Pacing Clin Electrophysiol 41(7):839–844

    Article  PubMed  Google Scholar 

  19. Pelliccia A et al (2005) Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the study group of sports cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the European society of cardiology. Eur Heart J 26(14):1422–1445

    Article  PubMed  Google Scholar 

  20. Vidaillet HJ Jr. et al (1987) Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome). N Engl J Med 317(2):65–69

    Article  PubMed  Google Scholar 

  21. Daubert C et al (1988) Failure of the exercise test to predict the anterograde refractory period of the accessory pathway in Wolff Parkinson White syndrome. Pacing Clin Electrophysiol 11(8):1130–1138

    Article  CAS  PubMed  Google Scholar 

  22. Czosek RJ et al (2011) Noninvasive risk stratification techniques in pediatric patients with ventricular preexcitation. Pacing Clin Electrophysiol 34(5):555–562

    Article  PubMed  Google Scholar 

  23. Dalili M et al (2014) Exercise testing in children with Wolff-Parkinson-White syndrome: what is its value? Pediatr Cardiol 35(7):1142–1146

    Article  CAS  PubMed  Google Scholar 

  24. Escudero CA et al (2020) Loss of ventricular preexcitation during noninvasive testing does not exclude high-risk accessory pathways: a multicenter study of WPW in children. Heart Rhythm 17(10):1729–1737

    Article  PubMed  Google Scholar 

  25. Brugada J et al (2020) 2019 ESC guidelines for the management of patients with supraventricular tachycardia. The task force for the management of patients with supraventricular tachycardia of the European society of cardiology (ESC). Eur Heart J 41(5):655–720

    Article  PubMed  Google Scholar 

  26. Klein GJ, Gulamhusein SS (1983) Intermittent preexcitation in the Wolff-Parkinson-White syndrome. Am J Cardiol 52(3):292–296

    Article  CAS  PubMed  Google Scholar 

  27. Telishevska M et al (2019) Catheter ablation in ASymptomatic PEDiatric patients with ventricular preexcitation: results from the multicenter “CASPED” study. Clin Res Cardiol 108(6):683–690

    Article  PubMed  Google Scholar 

  28. Obeyesekere MN, Klein GJ (2017) Application of the 2015 ACC/AHA/HRS guidelines for risk stratification for sudden death in adult patients with asymptomatic pre-excitation. J Cardiovasc Electrophysiol 28(7):841–848

    Article  PubMed  Google Scholar 

  29. Garg J et al (2017) Catheter ablation of accessory pathway: 14-year trends in utilization and complications in adults in the United States. Int J Cardiol 248:196–200

    Article  PubMed  Google Scholar 

  30. Mao J et al (2015) Catheter ablation of accessory pathways near the coronary sinus: value of defining coronary arterial anatomy. Heart Rhythm 12(3):508–514

    Article  PubMed  Google Scholar 

  31. Pappone C et al (2003) A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med 349(19):1803–1811

    Article  CAS  PubMed  Google Scholar 

  32. Wellens HJ (2005) Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram. Circulation 112(14):2201–2207 (discussion 2216)

    Article  PubMed  Google Scholar 

  33. Pappone C et al (2014) Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients. Circulation 130(10):811–819

    Article  PubMed  Google Scholar 

  34. Schmitt C, Deisenhofer I, Zrenner B (2006) Catheter ablation of cardiac arrhythmias. A practical approach. Steinkopff Verlag, Darmstadt

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabriele Hessling.

Ethics declarations

Interessenkonflikt

G. Hessling: speaker and travel fee Abbott, M. Telishevska: speaker and travel fee Abbott, S. Lengauer: speaker and travel fee Abbott, I. Deisenhofer: speaker and travel fee Abbott, Speaker and travel fee Biosense Webster, speaker and travel fee Boston Scientific.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hessling, G., Telishevska, M., Lengauer, S. et al. „Asymptomatisches WPW“. Herzschr Elektrophys 34, 114–121 (2023). https://doi.org/10.1007/s00399-023-00930-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00399-023-00930-x

Schlüsselwörter

Keywords

Navigation